Adicet Bio Inc expected to post a loss of 39 cents a share - Earnings Preview

ADICET Bio

03/05/2024 13:05

* Adicet Bio Inc  ACET.OQ   ACET.O  is expected to show no
change
in quarterly revenue when it reports  results on May 7
(estimated) for the period ending March 31 2024
    * 
    * ​LSEG's mean analyst estimate for Adicet Bio Inc is for a
loss
of 39 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 1.0%
in the last three months. ​
    * Wall Street's median 12-month price target for Adicet Bio
Inc is
$7.00​, above​ its last closing price of $1.41. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -0.72       -0.69      -0.69     Met     0.6
 Sep. 30 2023  -0.78       -0.74      -1.16     Missed  -57.3
 Jun. 30 2023  -0.71       -0.68      -0.75     Missed  -10​
 Mar. 31 2023  -0.71       -0.69      -0.72     Missed  -4.8
 ​​Dec.        0.29        -0.28      -0.72     Missed  -158.1
 31 2022                                                
 Sep. 30 2022  -0.55       -0.53      -0.53     Met     -0.6​
 Jun. 30 2022  -0.44       -0.45      -0.56     Missed  -23.1
 Mar. 31 2022  -0.24       -0.18      0.10      Beat    154.9
 This summary was machine generated May 3 at 12:05 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)